Skip to content
HowShorted

Endovia Health Sciences, Inc. short interest in 2023

In 2023, Endovia Health Sciences, Inc.'s disclosed short interest ran from 1.66% of shares outstanding on 13 Jan 2023 to 0.81% on 29 Dec 2023, a change of -0.85 percentage points. The year's high was 1.66% on 13 Jan 2023 and its low 0.25% on 15 May 2023, averaging 0.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.75 days on 31 Jul 2023. Full history: Endovia Health Sciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Endovia Health Sciences, Inc. in 2023

2023 in figures

Start of year
1.66% (13 Jan 2023)
End of year
0.81% (29 Dec 2023)
Change
-0.85 pp
High
1.66% (13 Jan 2023)
Low
0.25% (15 May 2023)
Average
0.73%
Highest days to cover
3.75 (31 Jul 2023)
SEC filings marked
5

Every report in 2023

Endovia Health Sciences, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20231.66%2.35
31 Jan 20231.47%3.57
15 Feb 20230.71%1.63
28 Feb 20230.38%1.00
15 Mar 20230.42%1.00
31 Mar 20230.37%1.0010-K filed
14 Apr 20230.38%1.00
28 Apr 20230.33%1.00
15 May 20230.25%1.00
31 May 20230.26%1.00
15 Jun 20230.61%1.2810-Q filed
30 Jun 20230.56%1.00
14 Jul 20230.79%2.78
31 Jul 20230.66%3.75
15 Aug 20230.97%1.0010-Q filed
31 Aug 20230.76%1.00results (8-K)
15 Sep 20230.66%1.93
29 Sep 20230.73%2.49
13 Oct 20230.92%1.92
31 Oct 20231.19%3.38
15 Nov 20230.94%1.9610-Q filed
30 Nov 20230.77%2.55
15 Dec 20230.84%3.69
29 Dec 20230.81%2.52

See also: Endovia Health Sciences, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.